Luminescent silica- based nanomaterials for biomedicine
; Ortega, Claudia Alicia ; Oppezzo, Pablo ; Agotegaray, Mariela Alejandra 
Otros responsables
Fecha
2019
Editorial
Fundación Revista Medicina
Revista
Título del libro
Nombre del evento
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas; VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento
2019-11-13
Institución organizadora
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
ISSN
0025-7680
eISSN
1669-9106
ISBN
Idioma
Inglés
Tipo del evento
Reunión
Clasificación temática
Palabras clave
Resumen
Silicon dioxide (SiO2), a material known as “silica” presents properties that make it a good candidate as a biomaterial: it has a very labile surface for functionalization, it is easy to synthesize and it is biocompatible. Calcination after synthesis of silica NPs yields luminescent nanomaterials. Fluorescent NPs themselves would offer enhanced functionality in terms of these properties with respect to conventional organic fluorophores. In this work, the influence of the synthesis method on the hydrodynamic diameter of silica fluorescent NPs was studied in order to obtain an optimal formulation as potential theranostic. Stöber process, involving tetraethylorthosilicate (TEOS) and 3-aminopropyltriethoxysilane (APTES), has been applied to obtain different formulations from increasing APTES initial concentration. After synthesis, the NPs were calcined at 450 °C. Characterization was performed by FTIR, TEM, DRX, fluorescence spectroscopy/microscopy and DLS to determine hydrodynamic diameter (Hd). NPs synthesized without APTES do not present fluorescent properties, while the APTES containing NPs are fluorescent. Increasing concentration of APTES induces larger NPs with low stability in physiological medium. The optimal synthesis condition resulted with a TEOS:APTES ratio of 1:0.1 rendering a Hd of 450 nm with polydispersion index near 0.20. This formulation is suitable for biomedical applications in terms of Hd and stability as potential theranostic agent for multiple pathologies, including Chronic Lymphocytic Leukemia that is of our particular interest. CLL is the most common adult leukemia in Western countries and is defined by the accumulation of mature, CD5+ B lymphocytes in peripheral blood, bone marrow and secondary lymphoid organs. Despite important progress in treatment, relapse occurs and this leukemia remains incurable in many cases. New therapeutic approaches by innovative tools acting in synergism with the last therapies approved in CLL are desirable.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
